24/7 Wall St. on MSN
LABU could rip higher if biotech finally gets its long-awaited breakout
Quick Read Direxion Daily S&P Biotech Bull 3X Shares (LABU) delivered 235% returns over the past year versus 65% for the ...
Zhengye receives a Nasdaq notice for failing to file its 2024 annual report on time. The company has 60 days to submit a compliance plan to avoid potential delisting. Get special access to three ...
Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...
Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...
TRINITY BIOTECH ($TRIB) is expected to release its quarterly earnings data on Thursday, May 22nd before market open, per Finnhub. Analysts are expecting revenue of ...
The Company expects Quarter 4, 2025 revenue within the range of approximately $11.5 million to $12.5 million. This compares to Quarter 4, 2024 revenue of $15.9 million, which was driven by a ...
(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a ...
The SEC has accused former investment adviser senior associate Rakesh Ahuja of using confidential biotech deal information to trade through a relative’s account, generating about $65,000 in alleged ...
Stramsen Biotech plans to create hundreds of jobs and boost the economy locally and elsewhere, as it welcomes investment banks and law firms. HOUSTON, March 10, 2026 /PRNewswire/ -- Stramsen Biotech ...
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “hold” rating reissued by research analysts at Jones Trading in a report released on Friday,Benzinga reports. Several other equities ...
Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...
SANTA ANA, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results